SEARCH

SEARCH BY CITATION

References

  • Aparicio, C. & Dahlbäck, B. (1996) Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene. The Biochemical Journal, 313 (Pt 2), 467472.
  • Arima, T., Motomura, M., Nishiura, Y., Tsujihata, M., Okajima, K., Abe, H. & Nagataki, S. (1992) Cerebral infarction in a heterozygote with variant antithrombin III. Stroke, 23, 18221825.
  • Atherosclerosis Thrombosis and Vascular Biology Italian Study Group (2003) No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation, 107, 11171122.
  • Austin, H., Chimowitz, M.I., Hill, H.A., Chaturvedi, S., Wechsler, L.R., Wityk, R.J., Walz, E., Wilterdink, J.L., Coull, B., Sila, C.A., Mitsias, P., Evatt, B. & Hooper, W.C. (2002) Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke, 33, 27622768.
  • Baglin, T., Luddington, R., Brown, K. & Baglin, C. (2003) Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet, 362, 523526.
  • Bank, I., Libourel, E.J., Middeldorp, S., Van Der Meer, J. & Buller, H.R. (2003) High rate of skin complications due to low-molecular-weight heparins in pregnant women. Journal of Thrombosis and Haemostasis, 1, 859861.
  • Bank, I., Libourel, E.J., Middeldorp, S., Van Pampus, E.C.M., Koopman, M.M.W., Hamulyak, K., Prins, M.H., Van Der Meer, J. & Buller, H.R. (2004a) Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Archives of Internal Medicine, 164, 19321937.
  • Bank, I., Scavenius, M.P.R.B., Buller, H.R. & Middeldorp, S. (2004b) Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice. Thrombosis Research, 113, 712.
  • Bank, I., Libourel, E.J., Middeldorp, S., Hamulyak, K., Van Pampus, E.C.M., Koopman, M.M.W., Prins, M.H., Van Der Meer, J. & Buller, H.R. (2005) Elevated levels of FVIII:c within families are associated with an increased risk for venous and arterial thrombosis. Journal of Thrombosis and Haemostasis, 3, 7984.
  • Beattie, S., Norton, M. & Doll, D. (1997) Coronary thrombosis associated with inherited protein S deficiency: a case report. Heart and Lung, 26, 7679.
  • Bertina, R.M., Broekmans, A.W., Van Der Linden, I. & Mertens, K. (1982) Protein C deficiency in a Dutch family with thrombotic disease. Thrombosis & Haemostasis, 48, 15.
  • Bertina, R.M., Koeleman, B.P., Koster, T., Rosendaal, F.R., Dirven, R.J., De Ronde, H., Van Der Velden, P.A. & Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 6467.
  • Bizzaro, N., Ghirardello, A., Zampieri, S., Iaccarino, L., Tozzoli, R., Ruffatti, A., Villalta, D., Tonutti, E. & Doria, A. (2007) Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study. Journal of Thrombosis and Haemostasis, 5, 11581164.
  • Bobrow, R.S. (2005) Excess factor VIII: a common cause of hypercoagulability. The Journal of the American Board of Family Practice, 18, 147149.
  • Boekholdt, S.M., Bijsterveld, N.R., Moons, A.H., Levi, M., Buller, H.R. & Peters, R.J. (2001) Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation, 104, 30633068.
  • Van Boven, H.H., Reitsma, P.H., Rosendaal, F.R., Bayston, T.A., Chowdhury, V., Bauer, K.A., Scharrer, I., Conard, J. & Lane, D.A. (1996) Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thrombosis & Haemostasis, 75, 417421.
  • Branson, H.E., Katz, J., Marble, R. & Griffin, J.H. (1983) Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet, 2, 11651168.
  • Brenner, B., Hoffman, R., Carp, H., Dulitzky, M., Younis, J. & for the LIVE-ENOX Investigators (2005) Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. Journal of Thrombosis and Haemostasis, 3, 227229.
  • Brown, K., Luddington, R., Williamson, D., Baker, P. & Baglin, T. (1997) Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene. British Journal of Haematology, 98, 907909.
  • Buller, H.R., Agnelli, G., Hull, R.D., Hyers, T.M., Prins, M.H. & Raskob, G.E. (2004) Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126, 401S428S.
  • Carod-Artal, F.J., Nunes, S.V., Portugal, D., Silva, T.V. & Vargas, A.P. (2005) Ischemic stroke subtypes and thrombophilia in young and elderly Brazilian stroke patients admitted to a rehabilitation hospital. Stroke, 36, 20122014.
  • Christiansen, S.C., Cannegieter, S.C., Koster, T., Vandenbroucke, J.P. & Rosendaal, F.R. (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA, 293, 23522361.
  • Cohn, D.M., Vansenne, F., Kaptein, A.A., De Borgie, C.A. & Middeldorp, S. (2008) The psychological impact of testing for thrombophilia: a systematic review. Journal of Thrombosis and Haemostasis, (in press).
  • Comp, P.C., Nixon, R.R., Cooper, M.R. & Esmon, C.T. (1984) Familial protein S deficiency is associated with recurrent thrombosis. Journal of Clinical Investigation, 74, 20822088.
  • Conard, J., Horellou, M.H., Van Dreden, P., Lecompte, T. & Samama, M. (1990) Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thrombosis & Haemostasis, 63, 319320.
  • Coppens, M., Van Mourik, J.A., Eckmann, C.M., Buller, H.R. & Middeldorp, S. (2007) Current practice of testing for hereditary thrombophilia in The Netherlands. Journal of Thrombosis and Haemostasis, 5, 19791981.
  • Croft, S.A., Daly, M.E., Steeds, R.P., Channer, K.S., Samani, N.J. & Hampton, K.K. (1999) The prothrombin 20210A allele and its association with myocardial infarction. Thrombosis and Haemostasis, 81, 861864.
  • Crowther, M.A., Ginsberg, J.S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., Clarke, A., Geerts, W., Forgie, M., Green, D., Costantini, L., Yacura, W., Wilson, S., Gent, M. & Kovacs, M.J. (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. The New England Journal of Medicine, 349, 11331138.
  • Cumming, A.M., Tait, R.C., Fildes, S., Yoong, A., Keeney, S. & Hay, C.R. (1995) Development of resistance to activated protein C during pregnancy. British Journal of Haematology, 90, 725727.
  • Curvers, J., Thomassen, M.C., Rimmer, J., Hamulyak, K., Van Der, M.J., Tans, G., Preston, F.E. & Rosing, J. (2002) Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test. Thrombosis and Haemostasis, 88, 511.
  • Cushman, M., Rosendaal, F.R., Psaty, B.M., Cook, E.F., Valliere, J., Kuller, L.H. & Tracy, R.P. (1998) Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study. Thrombosis and Haemostasis, 79, 912915.
  • Dacosta, A., Tardy-Poncet, B., Isaaz, K., Cerisier, A., Mismetti, P., Simitsidis, S., Reynaud, J., Tardy, B., Piot, M., Decousus, H. & Guyotat, D. (1998) Prevalence of factor V Leiden (APCR) and other inherited thrombophilias in young patients with myocardial infarction and normal coronary arteries. Heart, 80, 338340.
  • Dahlback, B. (1986) Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. Journal of Biological Chemistry, 261, 1202212027.
  • Dahlbäck, B., Carlsson, M. & Svensson, P.J. (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proceedings of the National Academy of Sciences of the United States of America, 90, 10041008.
  • De Stefano, V., Leone, G., Micalizzi, P., Teofili, L., Falappa, P.G., Pollari, G. & Bizzi, B. (1991) Arterial thrombosis as clinical manifestation of congenital protein C deficiency. Annals of Hematology, 62, 180183.
  • De Stefano, V., Chiusolo, P., Paciaroni, K., Casorelli, I., Rossi, E., Molinari, M., Servidei, S., Tonali, P.A. & Leone, G. (1998) Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood, 91, 35623565.
  • De Stefano, V., Martinelli, I., Mannucci, P.M., Paciaroni, K., Chiusolo, P., Casorelli, I., Rossi, E. & Leone, G. (1999) The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. New England Journal of Medicine, 341, 801806.
  • De Stefano, V., Simioni, P., Rossi, E., Tormene, D., Za, T., Pagnan, A. & Leone, G. (2006) The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. Haematologica, 91, 695698.
  • Deruelle, P., Denervaud, M., Hachulla, E., Ducloy-Bouthors, A.S., Valat, A.S., Puech, F., Trillot, N., Hatron, P.Y. & Subtil, D. (2006) Use of low-molecular-weight heparin from the first trimester of pregnancy: a retrospective study of 111 consecutive pregnancies. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 127, 7378.
  • Di Nisio, M., Peters, L.W. & Middeldorp, S. (2005) Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. The Cochrane Database of Systematic Reviews, Art. No.: CD004734, DOI: 10.1002/14651858.CD004734.pub2.
  • Doggen, C.J., Cats, V.M., Bertina, R.M. & Rosendaal, F.R. (1998) Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation, 97, 10371041.
  • Douay, X., Lucas, C., Caron, C., Goudemand, J. & Leys, D. (1998) Antithrombin, protein C and protein S levels in 127 consecutive young adults with ischemic stroke. Acta Neurologica Scandinavica, 98, 124127.
  • Dykes, A.C., Walker, I.D., McMahon, A.D., Islam, S.I. & Tait, R.C. (2001) A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. British Journal of Haematology, 113, 636641.
  • Egeberg, O. (1965) Inherited antithrombin deficiency causing thrombophilia. Thrombosis et Diathesis Haemorrhagica, 13, 516530.
  • Eichinger, S., Pabinger, I., Stumpflen, A., Hirschl, M., Bialonczyk, C., Schneider, B., Mannhalter, C., Minar, E., Lechner, K. & Kyrle, P.A. (1997) The risk of recurrent venous thromboembolism in patients with and without factor V Leiden. Thrombosis & Haemostasis, 77, 624628.
  • Eichinger, S., Weltermann, A., Mannhalter, C., Minar, E., Bialonczyk, C., Hirschl, M., Schonauer, V., Lechner, K. & Kyrle, P.A. (2002) The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism. Archives of Internal Medicine, 162, 23572360.
  • Eichinger, S., Minar, E., Bialonczyk, C., Hirschl, M., Quehenberger, P., Schneider, B., Weltermann, A., Wahl, D.G. & Kyrle, P.A. (2003) D-dimer levels and risk of recurrent venous thromboembolism. JAMA, 290, 10711074.
  • Empson, M., Lassere, M., Craig, J.C. & Scott, J.R. (2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. The Cochrane Database of Systematic Reviews, Art. No.: CD002859, DOI: 10.1002/14651858.CD002859.pub2.
  • Esmon, C.T. (2000) Regulation of blood coagulation. Biochimica et Biophysica Acta, 1477, 349360.
  • Finazzi, G., Marchioli, R., Brancaccio, V., Schinco, P., Wisloff, F., Musial, J., Baudo, F., Berrettini, M., Testa, S., D’Angelo, A., Tognoni, G. & Barbui, T. (2005) A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). Journal of Thrombosis and Haemostasis, 3, 848853.
  • Galli, M. & Barbui, T. (2005) Antiphospholipid syndrome: clinical and diagnostic utility of laboratory tests. Seminars in Thrombosis and Hemostasis, 31, 1724.
  • Galli, M., Luciani, D., Bertolini, G. & Barbui, T. (2003) Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood, 101, 18271832.
  • Gandrille, S., Borgel, D., Ireland, H., Lane, D.A., Simmonds, R., Reitsma, P.H., Mannhalter, C., Pabinger, I., Saito, H., Suzuki, K., Formstone, C., Cooper, D.N., Espinosa, Y., Sala, N., Bernardi, F. & Aiach, M. (1997) Protein S deficiency: a database of mutations. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thrombosis & Haemostasis, 77, 12011214.
  • Gandrille, S., Borgel, D., Sala, N., Espinosa-Parrilla, Y., Simmonds, R., Rezende, S., Lind, B., Mannhalter, C., Pabinger, I., Reitsma, P.H., Formstone, C., Cooper, D.N., Saito, H., Suzuki, K., Bernardi, F. & Aiach, M. (2000) Protein S deficiency: a database of mutations–summary of the first update. Thrombosis & Haemostasis, 84, 918.
  • Ganesan, V., McShane, M.A., Liesner, R., Cookson, J., Hann, I. & Kirkham, F.J. (1998) Inherited prothrombotic states and ischaemic stroke in childhood. Journal of Neurology, Neurosurgery, and Psychiatry, 65, 508511.
  • Ginsburg, K.S., Liang, M.H., Newcomer, L., Goldhaber, S.Z., Schur, P.H., Hennekens, C.H. & Stampfer, M.J. (1992) Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Annals of Internal Medicine, 117, 9971002.
  • Girolami, A., Simioni, P., Lazzaro, A.R. & Cordiano, I. (1989) Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study. Thrombosis and Haemostasis, 61, 144147.
  • Green, D., Otoya, J., Oriba, H. & Rovner, R. (1992) Protein S deficiency in middle-aged women with stroke. Neurology, 42, 10291033.
  • Grewal, R.P. & Goldberg, M.A. (1990) Stroke in protein C deficiency. American Journal of Medicine, 89, 538539.
  • Griffin, J.H., Evatt, B., Zimmerman, T.S., Kleiss, A.J. & Wideman, C. (1981) Deficiency of protein C in congenital thrombotic disease. Journal of Clinical Investigation, 68, 13701373.
  • Gris, J.C., Mercier, E., Quere, I., Lavigne-Lissalde, G., Cochery-Nouvellon, E., Hoffet, M., Ripart-Neveu, S., Tailland, M.L., Dauzat, M. & Mares, P. (2004) Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood, 103, 36953699.
  • De Groot, P.G., Lutters, B., Derksen, R.H., Lisman, T., Meijers, J.C. & Rosendaal, F.R. (2005) Lupus anticoagulants and the risk of a first episode of deep venous thrombosis. Journal of Thrombosis and Haemostasis, 3, 19931997.
  • Gunther, G., Junker, R., Strater, R., Schobess, R., Kurnik, K., Heller, C., Kosch, A. & Nowak-Gottl, U. (2000) Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors. Stroke, 31, 24372441.
  • Hackeng, T.M., Van’t Veer, C., Meijers, J.C. & Bouma, B.N. (1994) Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. Journal of Biological Chemistry, 269, 2105121058.
  • Hankey, G.J., Eikelboom, J.W., Van Bockxmeer, F.M., Lofthouse, E., Staples, N. & Baker, R.I. (2001) Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke, 32, 17931799.
  • Hayashi, K., Sone, T., Kondoh, J., Tsuboi, H., Sassa, H., Numaguchi, Y., Toki, Y., Okumura, K., Ito, T. & Hayakawa, T. (1997) Prevalence of activated protein C resistance in acute myocardial infarction in Japan. Japanese Heart Journal, 38, 769778.
  • Heeb, M.J., Kojima, Y., Greengard, J.S. & Griffin, J.H. (1995) Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V. Blood, 85, 34053411.
  • Heijboer, H., Brandjes, D.P., Buller, H.R., Sturk, A. & Ten Cate, J.W. (1990) Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. New England Journal of Medicine, 323, 15121516.
  • Henkens, C.M., Bom, V.J., Seinen, A.J. & Van Der Meer, J. (1995) Sensitivity to activated protein C; influence of oral contraceptives and sex. Thrombosis & Haemostasis, 73, 402404.
  • Hirsh, J., Piovella, F. & Pini, M. (1989) Congenital antithrombin III deficiency. Incidence and clinical features. American Journal of Medicine, 87, 34S38S.
  • Van Hylckama Vlieg, A., Van Der Linden, I.K., Bertina, R.M. & Rosendaal, F.R. (2000) High levels of factor IX increase the risk of venous thrombosis. Blood, 95, 36783682.
  • Van Hylckama Vlieg, A., Baglin, C.A., Bare, L.A., Rosendaal, F.R. & Baglin, T.P. (2008) Proof of principle of potential clinical utility of multiple SNP analysis for prediction of recurrent venous thrombosis. Journal of Thrombosis and Haemostasis, 6, 751754.
  • Jauniaux, E., Farquharson, R.G., Christiansen, O.B. & Exalto, N. (2006) Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Human Reproduction, 21, 21162222.
  • Juul, K., Tybjaerg-Hansen, A., Steffensen, R., Kofoed, S., Jensen, G. & Nordestgaard, B.G. (2002) Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. Blood, 100, 310.
  • Kalafatis, M., Bertina, R.M., Rand, M.D. & Mann, K.G. (1995) Characterization of the molecular defect in factor VR506Q. Journal of Biological Chemistry, 270, 40534057.
  • Kamphuisen, P.W., Lensen, R., Houwing-Duistermaat, J.J., Eikenboom, J.C., Harvey, M., Bertina, R.M. & Rosendaal, F.R. (2000) Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia. British Journal Haematology, 109, 519522.
  • Kamphuisen, P.W., Eikenboom, J.C., Rosendaal, F.R., Koster, T., Blann, A.D., Vos, H.L. & Bertina, R.M. (2001) High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene. British Journal of Haematology, 115, 156158.
  • Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M.J., Anderson, D.R., Turpie, A.G., Green, D., Ginsberg, J.S., Wells, P., MacKinnon, B. & Julian, J.A. (1999) A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine, 340, 901907.
  • Kearon, C., Ginsberg, J.S., Kovacs, M.J., Anderson, D.R., Wells, P., Julian, J.A., MacKinnon, B., Weitz, J.I., Crowther, M.A., Dolan, S., Turpie, A.G., Geerts, W., Solymoss, S., Van Nguyen, P., Demers, C., Kahn, S.R., Kassis, J., Rodger, M., Hambleton, J. & Gent, M. (2003) Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. The New England Journal of Medicine, 349, 631639.
  • Kenet, G., Sadetzki, S., Murad, H., Martinowitz, U., Rosenberg, N., Gitel, S., Rechavi, G. & Inbal, A. (2000) Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke, 31, 12831288.
  • Khamashta, M.A., Cuadrado, M.J., Mujic, F., Taub, N.A., Hunt, B.J. & Hughes, G.R. (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. New England Journal of Medicine, 332, 993997.
  • Koeleman, B.P., Reitsma, P.H. & Bertina, R.M. (1997) Familial thrombophilia: a complex genetic disorder. Seminars in Hematology, 34, 256264.
  • Kohler, J., Kasper, J., Witt, I. & Von Reutern, G.M. (1990) Ischemic stroke due to protein C deficiency. Stroke, 21, 10771080.
  • Van Korlaar, I., Vossen, C.Y., Rosendaal, F.R., Bovill, E.G., Naud, S., Cameron, L.D. & Kaptein, A.A. (2005) Attitudes toward genetic testing for thrombophilia in asymptomatic members of a large family with heritable protein C deficiency. Journal of Thrombosis and Haemostasis, 3, 24372444.
  • Koster, T., Rosendaal, F.R., De Ronde, H., Briët, E., Vandenbroucke, J.P. & Bertina, R.M. (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet, 342, 15031506.
  • Koster, T., Rosendaal, F.R., Reitsma, P.H., Van Der Velden, P.A., Briët, E. & Vandenbroucke, J.P. (1994) Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms–the Leiden Thrombophilia Study (LETS). Thrombosis and Haemostasis, 71, 719722.
  • Koster, T., Briët, E., Van Der Meer, F.J., Colly, L.P., Trienekens, P.H., Poort, S.R., Reitsma, P.H. & Vandenbroucke, J.P. (1995a) Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood, 85, 27562761.
  • Koster, T., Blann, A.D., Briët, E., Vandenbroucke, J.P. & Rosendaal, F.R. (1995b) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet, 345, 152155.
  • Kraaijenhagen, R.A., In’t Anker, P.S., Koopman, M.M., Reitsma, P.H., Prins, M.H., Van Den, E.A. & Buller, H.R. (2000) High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thrombosis & Haemostasis, 83, 59.
  • Kyrle, P.A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K. & Eichinger, S. (2000) High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. New England Journal of Medicine, 343, 457462.
  • Lalouschek, W., Schillinger, M., Hsieh, K., Endler, G., Tentschert, S., Lang, W., Cheng, S. & Mannhalter, C. (2005) Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years. Stroke, 36, 14051409.
  • Lane, D.A., Olds, R.J., Boisclair, M., Chowdhury, V., Thein, S.L., Cooper, D.N., Blajchman, M., Perry, D., Emmerich, J. & Aiach, M. (1993) Antithrombin III mutation database: first update. For the Thrombin and its Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thrombosis & Haemostasis, 70, 361369.
  • Lane, D.A., Bayston, T., Olds, R.J., Fitches, A.C., Cooper, D.N., Millar, D.S., Jochmans, K., Perry, D.J., Okajima, K., Thein, S.L. & Emmerich, J. (1997) Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thrombosis & Haemostasis, 77, 197211.
  • Legnani, C., Razzaboni, E., Gremigni, P., Ricci Bitti, P.E., Favaretto, E. & Palareti, G. (2006) Psychological impact of testing for thrombophilic alterations. Thrombosis & Haemostasis, 96, 348355.
  • Lim, W., Crowther, M.A. & Eikelboom, J.W. (2006) Management of antiphospholipid antibody syndrome: a systematic review. JAMA, 295, 10501057.
  • Lindmarker, P., Schulman, S., Sten-Linder, M., Wiman, B., Egberg, N. & Johnsson, H. (1999) The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation. Thrombosis and Haemostasis JID – 7608063, 81, 684–689.
  • Longstreth, Jr, W.T. , Rosendaal, F.R., Siscovick, D.S., Vos, H.L., Schwartz, S.M., Psaty, B.M., Raghunathan, T.E., Koepsell, T.D. & Reitsma, P.H. (1998) Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A). Stroke, 29, 577580.
  • Machin, S.J. (2003) Pros and cons of thrombophilia testing: cons. Journal of Thrombosis and Haemostasis, 1, 412413.
  • Mahasandana, C., Suvatte, V., Marlar, R.A., Manco-Johnson, M.J., Jacobson, L.J. & Hathaway, W.E. (1990) Neonatal purpura fulminans associated with homozygous protein S deficiency [letter]. Lancet, 335, 6162.
  • Makris, M., Preston, F.E., Beauchamp, N.J., Cooper, P.C., Daly, M.E., Hampton, K.K., Bayliss, P., Peake, I.R. & Miller, G.J. (1997) Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thrombosis & Haemostasis, 78, 14261429.
  • Mansourati, J., Da Costa, A., Munier, S., Mercier, B., Tardy, B., Ferec, C., Isaaz, K. & Blanc, J.J. (2000) Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography. Thrombosis and Haemostasis, 83, 822825.
  • Manzar, K.J., Padder, F.A., Conrad, A.R., Freeman, I. & Jonas, E.A. (1997) Acute myocardial infarction with normal coronary artery: a case report and review of literature. American Journal of the Medical Sciences, 314, 342345.
  • Marchetti, M., Pistorio, A. & Barosi, G. (2000) Extended anticoagulation for prevention of recurrent venous thromboembolism in carriers of factor V Leiden: cost-effectiveness analysis. Thrombosis & Haemostasis, 84, 752757.
  • Marlar, R.A., Montgomery, R.R. & Broekmans, A.W. (1989) Report on the diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the ICTH-Subcommittee on Protein C and Protein S. Thrombosis & Haemostasis, 61, 529531.
  • Martinez, H.R., Rangel-Guerra, R.A. & Marfil, L.J. (1993) Ischemic stroke due to deficiency of coagulation inhibitors. Report of 10 young adults. Stroke, 24, 1925.
  • Van Der Meer, F.J., Rosendaal, F.R., Vandenbroucke, J.P. & Briet, E. (1996) Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants. Thrombosis & Haemostasis, 76, 1216.
  • Meijers, J.C.M., Tekelenburg, W.L.H., Bouma, B.N., Bertina, R.M. & Rosendaal, F.R. (2000) High levels of factor XI as a risk factor for venous thrombosis. New England Journal of Medicine, 342, 696701.
  • Meinardi, J.R., Henkens, C.M., Heringa, M.P. & Van Der Meer, J. (1997) Acquired APC resistance related to oral contraceptives and pregnancy and its possible implications for clinical practice. Blood Coagulation & Fibrinolysis, 8, 152154.
  • Meinardi, J.R., Middeldorp, S., De Kam, P.J., Koopman, M.M.W., Van Pampus, E.C.M., Hamulyak, K., Prins, M.H., Buller, H.R. & Van Der Meer, J. (1999) Increased risk for fetal loss in carriers of the factor V Leiden mutation. Annals of Internal Medicine, 130, 736739.
  • Meinardi, J.R., Middeldorp, S., De Kam, P.J., Koopman, M.M.W., Van Pampus, E.C.M., Hamulyak, K., Prins, M.H., Buller, H.R. & Van Der Meer, J. (2001) Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect. Blood Coagulation & Fibrinolysis, 12, 713720.
  • Meinardi, J.R., Middeldorp, S., De Kam, P.J., Koopman, M.M.W., Van Pampus, E.C.M., Hamulyak, K., Prins, M.H., Buller, H.R. & Van Der Meer, J. (2002) The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders. British Journal of Haematology, 116, 625631.
  • Middeldorp, S. (2007a) Thrombophilia and pregnancy complications: cause or association? Journal of Thrombosis and Haemostasis, 5, 276282.
  • Middeldorp, S. (2007b) Pregnancy failure and heritable thrombophilia. Seminars in Hematology, 44, 9397.
  • Miles, J.S., Miletich, J.P., Goldhaber, S.Z., Hennekens, C.H. & Ridker, P.M. (2001) G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism. Journal of the American College of Cardiology, 37, 215218.
  • Miletich, J., Sherman, L. & Broze, Jr, G. (1987) Absence of thrombosis in subjects with heterozygous protein C deficiency. New England Journal of Medicine, 317, 991996.
  • Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derksen, R.H., De Groot, P.G., Koike, T., Meroni, P.L., Reber, G., Shoenfeld, Y., Tincani, A., Vlachoyiannopoulos, P.G. & Krilis, S.A. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 4, 295306.
  • Munts, A.G., Van Genderen, P.J., Dippel, D.W., Van Kooten, F. & Koudstaal, P.J. (1998) Coagulation disorders in young adults with acute cerebral ischaemia. Journal of Neurology, 245, 2125.
  • Naess, I.A., Christiansen, S.C., Cannegieter, S.C., Rosendaal, F.R. & Hammerstroem, J. (2006) A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study). Journal of Thrombosis and Haemostasis, 4, 4449.
  • Nicolaes, G.A., Tans, G., Thomassen, M.C.L.G.D., Hemker, H.C., Pabinger, I., Varadi, K., Schwarz, H.P. & Rosing, J. (1995) Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. Journal of Biological Chemistry, 270, 2115821166.
  • O’Donnell, J. & Laffan, M. (2001) Elevated plasma factor VIII levels–a novel risk factor for venous thromboembolism. Clinical Laboratory, 47, 16.
  • Olivieri, O., Friso, S., Manzato, F., Guella, A., Bernardi, F., Lunghi, B., Girelli, D., Azzini, M., Brocco, G., Russo, C. & Corrocher, R. (1995) Resistance to activated protein C in healthy women taking oral contraceptives. British Journal Haematology, 91, 465470.
  • Opatrny, L., David, M., Kahn, S.R., Shrier, I. & Rey, E. (2006) Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmunie disease: a metaanalysis. Journal of Rheumatology, 33, 22142221.
  • Pabinger, I., Brucker, S., Kyrle, P.A., Schneider, B., Korninger, H.C., Niessner, H. & Lechner, K. (1992) Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening. Blood Coagulation & Fibrinolysis, 3, 547553.
  • Palareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., D’Angelo, A., Pengo, V., Erba, N., Moia, M., Ciaverella, N., Devoto, G., Berrettini, M. & Musolesi, S. (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet, 348, 423428.
  • Palareti, G., Legnani, C., Cosmi, B., Guazzaloca, G., Pancani, C. & Coccheri, S. (2002) Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thrombosis and Haemostasis, 87, 712.
  • Peterman, M.A. & Roberts, W.C. (2003) Syndrome of protein C deficiency and anterior wall acute myocardial infarction at a young age from a single coronary occlusion with otherwise normal coronary arteries. American Journal of Cardiology, 92, 768770.
  • Pezzini, A., Grassi, M., Del, Z.E., Archetti, S., Spezi, R., Vergani, V., Assanelli, D., Caimi, L. & Padovani, A. (2005) Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults. Stroke, 36, 533539.
  • Pomp, E.R., Le Cessie, S., Rosendaal, F.R. & Doggen, C.J. (2007) Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. British Journal of Haematology, 132, 289296.
  • Poort, S.R., Rosendaal, F.R., Reitsma, P.H. & Bertina, R.M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 36983703.
  • Prandoni, P., Lensing, A.W., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A.M., Polistena, P., Bernardi, E. & Prins, M.H. (1996a) The long-term clinical course of acute deep venous thrombosis. Annals of Internal Medicine, 125, 17.
  • Prandoni, P., Simioni, P. & Girolami, A. (1996b) Antiphospholipid antibodies, recurrent thromboembolism, and intensity of warfarin anticoagulation. Thrombosis and Haemostasis, 75, 859.
  • Preston, F.E., Rosendaal, F.R., Walker, I.D., Briet, E., Berntorp, E., Conard, J., Fontcuberta, J., Makris, M., Mariani, G., Noteboom, W., Pabinger, I., Legnani, C., Scharrer, I., Schulman, S. & Van Der Meer, F.J.M. (1996) Increased fetal loss in women with heritable thrombophilia. Lancet, 348, 913916.
  • Rai, R. & Regan, L. (2006) Recurrent miscarriage. The Lancet, 368, 601611.
  • Rallidis, L.S., Belesi, C.I., Manioudaki, H.S., Chatziioakimidis, V.K., Fakitsa, V.C., Sinos, L.E., Laoutaris, N.P. & Apostolou, T.S. (2003) Myocardial infarction under the age of 36: prevalence of thrombophilic disorders. Thrombosis and Haemostasis, 90, 272278.
  • Rance, A., Emmerich, J. & Fiessinger, J.N. (1997) Anticardiolipin antibodies and recurrent thromboembolism. Thrombosis and Haemostasis, 77, 221222.
  • Rees, D.C. (1996) The population genetics of factor V Leiden (Arg506Gln). British Journal of Haematology, 95, 579586.
  • Reitsma, P.H., Bernardi, F., Doig, R.G., Gandrille, S., Greengard, J.S., Ireland, H., Krawczak, M., Lind, B., Long, G.L., Poort, S.R., Saito, H., Sala, N., Witt, I. & Cooper, D.N. (1995) Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH. Thrombosis & Haemostasis, 73, 876889.
  • Rey, E., Kahn, S.R., David, M. & Shrier, I. (2003) Thrombophilic disorders and fetal loss: a meta-analysis. Lancet, 361, 901908.
  • Ridker, P.M., Hennekens, C.H., Lindpaintner, K., Stampfer, M.J., Eisenberg, P.R. & Miletich, J.P. (1995a) Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. New England Journal of Medicine, 332, 912917.
  • Ridker, P.M., Hennekens, C.H., Lindpaintner, K., Stampfer, M.J., Eisenberg, P.R. & Miletich, J.P. (1995b) Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. The New England Journal of Medicine, 332, 912917.
  • Ridker, P.M., Hennekens, C.H. & Miletich, J.P. (1999) G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation, 99, 9991004.
  • Rintelen, C., Pabinger, I., Knobl, P., Lechner, K. & Mannhalter, C. (1996) Probability of recurrence of thrombosis in patients with and without factor V Leiden. Thrombosis & Haemostasis, 75, 229232.
  • Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G.D.O., Walker, I.D., Greaves, M., Brenkel, I., Regan, L. & Greer, I.A. (2006) Thrombophilia in pregnancy: a systematic review. British Journal of Haematology, 132, 171196.
  • Rodeghiero, F. & Tosetto, A. (1999) Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Annals of Internal Medicine, 130, 643650.
  • Rodger, M.A., Paidas, M.J., Mclintock, C., Middeldorp, S., Kahn, S.R., Martinelli, I., Hague, W., Rosene-Montella, S. & Greer, I.A. (2008) Inherited thrombophilia and pregnancy complications revisited: association not proven causal and antithrombotic prophylaxis is experimental. Obstetrics and Gynecology, (in press).
  • Rosendaal, F.R., Koster, T., Vandenbroucke, J.P. & Reitsma, P.H. (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood, 85, 15041508.
  • Rosendaal, F.R., Siscovick, D.S., Schwartz, S.M., Beverly, R.K., Psaty, B.M., Longstreth, Jr, W.T., Raghunathan, T.E., Koepsell, T.D. & Reitsma, P.H. (1997) Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood, 89, 28172821.
  • Rosendaal, F.R., Doggen, C.J., Zivelin, A., Arruda, V.R., Aiach, M., Siscovick, D.S., Hillarp, A., Watzke, H.H., Bernardi, F., Cumming, A.M., Preston, F.E. & Reitsma, P.H. (1998) Geographic distribution of the 20210 G to A prothrombin variant. Thrombosis and Haemostasis, 79, 706708.
  • Rosing, J., Tans, G., Nicolaes, G.A., Thomassen, M.C.L.G.D., Van Oerle, R., Van Der Ploeg, P.M., Heijnen, P., Hamulyak, K. & Hemker, H.C. (1997) Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. British Journal of Haematology, 97, 233238.
  • Ruiz-Irastorza, G., Hunt, B.J. & Khamashta, M.A. (2007) A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis and Rheumatism, 57, 14871495.
  • Runchey, S.S., Folsom, A.R., Tsai, M.Y., Cushman, M. & McGovern, P.D. (2002) Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study. British Journal of Haematology, 119, 10051010.
  • Sanson, B.J., Friederich, P.W., Simioni, P., Zanardi, S., Huisman, M.V., Girolami, A., Cate, J.W.P. & Prins, M.H. (1996) The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thrombosis & Haemostasis, 75, 387388.
  • Sanson, B.J., Simioni, P., Tormene, D., Moia, M., Friederich, P.W., Huisman, M.V., Prandoni, P., Bura, A., Rejto, L., Wells, P., Mannucci, P.M., Girolami, A., Buller, H.R. & Prins, M.H. (1999) The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood, 94, 37023706.
  • Schulman, S., Svenungsson, E. & Granqvist, S. (1998) Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. American Journal of Medicine, 104, 332338.
  • Segev, A., Ellis, M.H., Segev, F., Friedman, Z., Reshef, T., Sparkes, J.D., Tetro, J., Pauzner, H. & David, D. (2005) High prevalence of thrombophilia among young patients with myocardial infarction and few conventional risk factors. International Journal of Cardiology, 98, 421424.
  • Simioni, P., Sanson, B.J., Prandoni, P., Tormene, D., Friederich, P.W., Girolami, B., Gavasso, S., Huisman, M.V., Buller, H.R., Ten Cate, J.W., Girolami, A. & Prins, M.H. (1999) The incidence of venous thromboembolism in families with inherited thrombophilia. Thrombosis & Haemostasis, 81, 198202.
  • Simioni, P., Prandoni, P., Lensing, A.W., Manfrin, D., Tormene, D., Gavasso, S., Girolami, B., Sardella, C., Prins, M. & Girolami, A. (2000) Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Blood JID - 7603509, 96, 3329–3333.
  • Smiles, A.M., Jenny, N.S., Tang, Z., Arnold, A., Cushman, M. & Tracy, R.P. (2002) No association of plasma prothrombin concentration or the G20210A mutation with incident cardiovascular disease: results from the Cardiovascular Health Study. Thrombosis and Haemostasis, 87, 614621.
  • Stearns-Kurosawa, D.J., Kurosawa, S., Mollica, J.S., Ferrell, G.L. & Esmon, C.T. (1996) The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proceedings of the National Academy of Sciences of the United States of America, 93, 1021210216.
  • Tait, R.C., Walker, I.D., Perry, D.J., Islam, S.I., Daly, M.E., McCall, F., Conkie, J.A. & Carrell, R.W. (1994) Prevalence of antithrombin deficiency in the healthy population. British Journal of Haematology, 87, 106112.
  • Tans, G., Curvers, J., Middeldorp, S., Thomassen, M.C.L.G.D., Meijers, J.C.M., Prins, M.H., Bouma, B.N., Buller, H.R. & Rosing, J. (2000) A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways. Thrombosis & Haemostasis, 84, 1521.
  • Tans, G., Van Hylckama Vlieg, A., Thomassen, M.C., Curvers, J., Bertina, R.M., Rosing, J. & Rosendaal, F.R. (2003) Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women. British Journal of Haematology, 122, 465470.
  • Taylor, Jr, F.B., Peer, G.T., Lockhart, M.S., Ferrell, G. & Esmon, C.T. (2001) Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood, 97, 16851688.
  • Tiong, I.Y., Alkotob, M.L. & Ghaffari, S. (2003) Protein C deficiency manifesting as an acute myocardial infarction and ischaemic stroke. Heart, 89, E7.
  • Urbanus, R.T., Derksen, R.H. & De Groot, P.G. (2008) Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome. Blood Reviews, 22, 93105.
  • Vandenbroucke, J.P., Koster, T., Briët, E., Reitsma, P.H., Bertina, R.M. & Rosendaal, F.R. (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet, 344, 14531457.
  • DeVeber, G., Monagle, P., Chan, A., MacGregor, D., Curtis, R., Lee, S., Vegh, P., Adams, M., Marzinotto, V., Leaker, M., Massicotte, M.P., Lillicrap, D. & Andrew, M. (1998) Prothrombotic disorders in infants and children with cerebral thromboembolism. Archives of Neurology, 55, 15391543.
  • Vink, R., Kraaijenhagen, R.A., Levi, M. & Buller, H.R. (2003) Individualised duration of oral anticoagulant therapy for deep vein thrombosis based on a decision model. Journal of Thrombosis and Haemostasis, 1, 25232530.
  • Virchow, R. (1856) Thrombose und Embolie. Gefässentzündung und septische Infektion. Gesammelte Abhandlungen zur wissenschaftlichen Medicin. Von Meidinger & Sohn, Frankfurt am Main.
  • De Visser, M.C.H., Rosendaal, F.R. & Bertina, R.M. (1999) A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. Blood, 93, 12711276.
  • Voorberg, J., Roelse, J., Koopman, R., Büller, H.R., Berends, F., Ten Cate, J.W., Mertens, K. & Van Mourik, J.A. (1994) Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Lancet, 343, 15351536.
  • Vossen, C.Y., Hasstedt, S.J., Rosendaal, F.R., Callas, P.W., Bauer, K.A., Broze, G.J., Hoogendoorn, H., Long, G.L., Scott, B.T. & Bovill, E.G. (2004) Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family. Journal of Thrombosis and Haemostasis, 2, 242247.
  • Vossen, C.Y., Conard, J., Fontcuberta, J., Makris, M., Van Der Meer, F.J., Pabinger, I., Palareti, G., Preston, F.E., Scharrer, I., Souto, J.C., Svensson, P., Walker, I.D. & Rosendaal, F.R. (2005) Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). Journal of Thrombosis and Haemostasis, 3, 459464.
  • Walker, M.C., Ferguson, S.E. & Allen, V.M. (2003) Heparin for pregnant women with acquired or inherited thrombophilias. The Cochrane Database of Systematic Reviews, Art. No.: CD003580, DOI: 10.1002/14651858.CD003580.
  • Weitz, J.I., Middeldorp, S., Geerts, W. & Heit, J.A. (2004) Thrombophilia and new anticoagulant drugs. Hematology (Am Soc Hematol Educ Program), 2004, 424438.
  • Weltermann, A., Eichinger, S., Bialonczyk, C., Minar, E., Hirschl, M., Quehenberger, P., Schonauer, V. & Kyrle, P.A. (2003) The risk of recurrent venous thromboembolism among patients with high factor IX levels. Journal of Thrombosis and Haemostasis, 1, 2832.
  • Wilson, W.A., Gharavi, A.E., Koike, T., Lockshin, M.D., Branch, D.W., Piette, J.C., Brey, R., Derksen, R., Harris, E.N., Hughes, G.R., Triplett, D.A. & Khamashta, M.A. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis and Rheumatism, 42, 13091311.
  • Wu, O., Robertson, L., Twaddle, S., Lowe, G.D., Clark, P., Greaves, M., Walker, I.D., Langhorne, P., Brenkel, I., Regan, L. & Greer, I. (2006) Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technology Assessment, 10, 1110.
  • Zanon, E., Prandoni, P., Vianello, F., Saggiorato, G., Carraro, G., Bagatella, P. & Girolami, A. (1999) Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism. Thrombosis Research, 96, 269274.
  • Zenz, W., Bodo, Z., Plotho, J., Streif, W., Male, C., Bernert, G., Rauter, L., Ebetsberger, G., Kaltenbrunner, K., Kurnik, P., Lischka, A., Paky, F., Ploier, R., Hofler, G., Mannhalter, C. & Muntean, W. (1998) Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke. Thrombosis and Haemostasis, 80, 763766.
  • Zoller, B., Berntsdotter, A., Garcia de Frutos, P. & Dahlback, B. (1995) Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood, 85, 35183523.